...
首页> 外文期刊>Spectrochimica acta, Part A. Molecular and biomolecular spectroscopy >Design and optimization of a luminescent Samarium complex of isoprenaline: A chemometric approach based on Factorial design and Box-Behnken response surface methodology
【24h】

Design and optimization of a luminescent Samarium complex of isoprenaline: A chemometric approach based on Factorial design and Box-Behnken response surface methodology

机译:异腺嘌呤发光钐综合体的设计与优化:基于因子设计和Box-Behnken响应面方法的化学计量方法

获取原文
获取原文并翻译 | 示例
           

摘要

A chemometrically optimized procedure has been developed for the determination of isoprenaline (ISO) in the parent substance as well as in its respective pharmaceutical preparation. It is worth mentioning that although spectroscopic determination of Isoprenaline metal complexes has been described in literature, yet, no methods for the quantification of Isoprenaline with Samarium nor any other lanthanide metal have been reported. Fractional factorial design (FFD) was implemented in the initial screening procedure of the four designated factors, namely, reaction time (RT), metal volume (MV), pH and temperature (T) followed by Response Surface Methodology (RSM) optimization tool performed by the aid of Box Behnken design (BBD).The proposed techniques are based on a multivariate approach where a complexation reaction between Isoprenaline (ISO) and Samarium III (Sm3+ ) metal was exploited for the first time to synthesize novel fluorescence and absorbance probes of ISOSm. Maximum fluorescence intensity (Y1) as well as maximum absorbance (Y2) of the produced complex were attained at lambda ex /lambda em = 315/450 and lambda 295 nm for spectrofluorimetric and spectrophotometric determinations, respectively, against blank solutions. Using assessment quality tools such as, Pareto charts, normal probability plots and statistical analysis of variance testing (ANOVA), significant factors were successfully indicated (p 0.05). Furthermore, the proposed methods verified specificity and accuracy for the determination of Isoprenaline in its pure and pharmaceutical preparation using spectrofluorimetric (Technique A) and spectrophotometric (Technique B) techniques, respectively. Linearity was obtained in the range of (0.02-0.50 mu g/mL) and (2-12 mu g/mL) upon employing both techniques A and B, respectively. Furthermore, limit of detection (LOD) and limit of quantification (LOQ), were found to be 5.1877 * 10 (-3) mu g/mL, 0.01572 mu g/mL and 0.5593 mu g/mL, 1.6949 mu g/mL, upon em
机译:甲chemometrically优化过程已经发展为异丙肾上腺素的在母体物质以及在其各自的药物制剂中的判定(ISO)。值得一提的是,虽然异丙肾上腺素金属配合物的光谱测定在文献中进行了描述,然而,对于异丙肾上腺素的定量钐或任何其他的镧系金属没有方法已被报道。部分因子设计(FFD)是在四个指定因子的初始筛选过程中实现,即,反应时​​间(RT),金属体积(MV),pH值和温度(T),然后响应面分析法(RSM)优化工具所执行选择盒Behnken法设计的助剂(BBD)。该提出的技术是基于一个多变量的方法,其中异丙肾上腺素(ISO)和钐III之间的络合反应(钐+)金属被利用首次合成的新颖的荧光和吸收探针ISOSm。最大荧光强度(Y1),以及所产生的复杂的最大吸光度(Y2)被实现在拉姆达EX /λ发射=450分之315和λ295nm的用于荧光法和分光光度法测定,分别针对空白溶液。使用评估质量的工具,如,排列图,正态概率图和方差测试(ANOVA)进行统计分析,显著因素被成功指示(P< 0.05)。此外,所提出的方法分别验证特异性和准确性为异丙肾上腺素以其纯和药物制剂使用荧光法(技术A)的确定和分光光度法(技术B)的技术。线性度的范围内时采用这两种技术A和B,分别获得(0.02-0.50亩克/毫升)和(2-12亩克/毫升)。此外,检测(LOD)和定量限(LOQ)的限制的限制,被发现是5.1877×10(-3)亩克/毫升,0.01572亩克/ mL和0.5593亩克/毫升,1.6949亩克/毫升,在EM

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号